Trial intelligence / Profile preview

Bovine Alkaline Phosphatase in Sepsis Patients with Renal Failure

NCT00511186Phase 2Terminated

Sponsor
AM-Pharma
Start
May 2008
Primary completion
Dec 2009
Countries
2
01

Overview

A Phase 2 trial of bovine intestinal alkaline phosphatase in sepsis, acute kidney injury (AKI), sponsored by AM-Pharma. Started May 2008; status: terminated.

02

Drugs

bovine intestinal alkaline phosphatase
03

Conditions

sepsisacute kidney injury (AKI)

Beyond the preview

Go deeper on NCT00511186.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00511186.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call